Published in Medical Letter on the CDC and FDA, August 28th, 2005
According to a study from India, "This report presents the 5-year follow-up of 137 children with respiratory tuberculosis enrolled in a randomized clinical trial of two different antituberculosis regimens 9HR and 2HRZ(3)/4RH(2). Both regimens had similar cure rates, with low relapse rates and mortality."
"Of 134 children followed up to 5 years, 86% had normal radiographs, with more sequelae in the 9HR group (15 vs. 1.5%, p<0.01). One patient relapsed and there was one accidental death," reported S. Swaminathan and colleagues at the Indian Council for Medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA